Canada · Delayed Price · Currency is CAD Gemina Laboratories Statistics
Total Valuation
CSE:GLAB has a market cap or net worth of CAD 4.59 million. The enterprise value is 4.83 million.
| Market Cap | 4.59M |
| Enterprise Value | 4.83M |
Important Dates
The next estimated earnings date is Thursday, May 28, 2026.
| Earnings Date | May 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:GLAB has 76.57 million shares outstanding. The number of shares has increased by 2.03% in one year.
| Current Share Class | 76.57M |
| Shares Outstanding | 76.57M |
| Shares Change (YoY) | +2.03% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 422.34 |
| PB Ratio | -0.89 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 7,893.91 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.65 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
| Current Ratio | 0.01 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -36.06 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -134.42% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 55.22% |
| Revenue Per Employee | 1,813 |
| Profits Per Employee | -488,213 |
| Employee Count | 6 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.31% in the last 52 weeks. The beta is -0.05, so CSE:GLAB's price volatility has been lower than the market average.
| Beta (5Y) | -0.05 |
| 52-Week Price Change | -92.31% |
| 50-Day Moving Average | 0.44 |
| 200-Day Moving Average | 0.64 |
| Relative Strength Index (RSI) | 28.99 |
| Average Volume (20 Days) | 47,758 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSE:GLAB had revenue of CAD 10,878 and -2.93 million in losses. Loss per share was -0.04.
| Revenue | 10,878 |
| Gross Profit | 10,878 |
| Operating Income | -2.84M |
| Pretax Income | -2.93M |
| Net Income | -2.93M |
| EBITDA | -2.90M |
| EBIT | -2.84M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has -613 in cash and 240,110 in debt, with a net cash position of -240,723 or -0.00 per share.
| Cash & Cash Equivalents | -613 |
| Total Debt | 240,110 |
| Net Cash | -240,723 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -5.14M |
| Book Value Per Share | -0.07 |
| Working Capital | -6.20M |
Cash Flow
| Operating Cash Flow | 582 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -26,104.50% |
| Pretax Margin | -26,928.43% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:GLAB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.03% |
| Shareholder Yield | -2.03% |
| Earnings Yield | -63.76% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CSE:GLAB has an Altman Z-Score of -37.66 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -37.66 |
| Piotroski F-Score | 2 |